These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 25694650)
1. Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination. Cnops L; Gerard M; Vandenberg O; Van den Wijngaert S; Heyndrickx L; Willems E; Demeulemeester K; De Clerck H; Dediste A; Callens S; De Munter P; Vlieghe E; Bottieau E; Wuillaume F; Van Esbroeck M; Ariën KK Clin Infect Dis; 2015 Jun; 60(11):1725-6. PubMed ID: 25694650 [No Abstract] [Full Text] [Related]
2. Difficulties of interpretation of Zaire Ebola Virus PCR results and implication in the field. Janvier F; Gorbatch S; Queval L; Top J; Vigier C; Cotte J; Foissaud V J Clin Virol; 2015 Jun; 67():36-7. PubMed ID: 25959155 [No Abstract] [Full Text] [Related]
3. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676 [TBL] [Abstract][Full Text] [Related]
4. [Recent Advances in Vaccines and Drugs Against the Ebola Virus]. Zhu X; Yao C; Wei Y; Kou Z; Hu K Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536 [TBL] [Abstract][Full Text] [Related]
5. Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know? Huttner A; Siegrist CA Expert Rev Vaccines; 2018 Dec; 17(12):1105-1110. PubMed ID: 30422031 [TBL] [Abstract][Full Text] [Related]
6. Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens. Southern TR; Racsa LD; Albariño CG; Fey PD; Hinrichs SH; Murphy CN; Herrera VL; Sambol AR; Hill CE; Ryan EL; Kraft CS; Campbell S; Sealy TK; Schuh A; Ritchie JC; Lyon GM; Mehta AK; Varkey JB; Ribner BS; Brantly KP; Ströher U; Iwen PC; Burd EM J Clin Microbiol; 2015 Sep; 53(9):2956-60. PubMed ID: 26157148 [TBL] [Abstract][Full Text] [Related]
7. [Potential vaccine candidates against Ebola and the first vaccine against chikungunya virus infection]. Nau JY Rev Med Suisse; 2014 Aug; 10(439):1570-1. PubMed ID: 25272676 [No Abstract] [Full Text] [Related]
9. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Farooq F; Beck K; Paolino KM; Phillips R; Waters NC; Regules JA; Bergmann-Leitner ES Sci Rep; 2016 Jun; 6():27944. PubMed ID: 27323685 [TBL] [Abstract][Full Text] [Related]
10. Use of the FilmArray System for Detection of Zaire ebolavirus in a Small Hospital in Bo, Sierra Leone. Leski TA; Ansumana R; Taitt CR; Lamin JM; Bangura U; Lahai J; Mbayo G; Kanneh MB; Bawo B; Bockarie AS; Scullion M; Phillips CL; Horner CP; Jacobsen KH; Stenger DA J Clin Microbiol; 2015 Jul; 53(7):2368-70. PubMed ID: 25972415 [TBL] [Abstract][Full Text] [Related]
11. Detection of Zaire Ebola virus by real-time reverse transcription-polymerase chain reaction, Sierra Leone, 2014. Liu L; Sun Y; Kargbo B; Zhang C; Feng H; Lu H; Liu W; Wang C; Hu Y; Deng Y; Jiang J; Kang X; Yang H; Jiang Y; Yang Y; Kargbo D; Qian J; Chen W J Virol Methods; 2015 Sep; 222():62-5. PubMed ID: 26025458 [TBL] [Abstract][Full Text] [Related]
12. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a real-time EBOV-L-RT-qPCR for detection of Zaire ebolavirus. Jääskeläinen AJ; Moilanen K; Aaltonen K; Putkuri N; Sironen T; Kallio-Kokko H; Vapalahti O J Clin Virol; 2015 Jun; 67():56-8. PubMed ID: 25959160 [TBL] [Abstract][Full Text] [Related]
14. Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine. Medaglini D; Siegrist CA Curr Opin Virol; 2017 Apr; 23():88-94. PubMed ID: 28460340 [TBL] [Abstract][Full Text] [Related]
15. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay. Jansen van Vuren P; Grobbelaar A; Storm N; Conteh O; Konneh K; Kamara A; Sanne I; Paweska JT J Clin Microbiol; 2016 Feb; 54(2):359-67. PubMed ID: 26637383 [TBL] [Abstract][Full Text] [Related]
16. Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort. Ledgerwood JE Lancet Infect Dis; 2015 Oct; 15(10):1117-1119. PubMed ID: 26248511 [No Abstract] [Full Text] [Related]
17. Rapid Determination of Ebolavirus Infectivity in Clinical Samples Using a Novel Reporter Cell Line. Kainulainen MH; Nichol ST; Albariño CG; Spiropoulou CF J Infect Dis; 2017 Dec; 216(11):1380-1385. PubMed ID: 29029133 [TBL] [Abstract][Full Text] [Related]